Delivery Order SPE2DB22D2211-SPE2DB24FPDN1

Award Date 8/15/24
Potential Completion Date 8/16/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of IMOVAX Rabies Vaccine vials. The $2,281.90 fixed-price delivery order was issued by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), which supports the Department of Defense (DoD). The contract has an ultimate completion date of August 16, 2023. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) valued...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of IMOVAX RABIES VACCINE VIALS to the Defense Logistics Agency (DLA). The $2,158.70 firm-fixed-price delivery order has a ceiling value and an ultimate completion date of July 10, 2024. The contract does not have a set-aside designation. Amerisourcebergen is a major pharmaceutical distribution company that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of IMOVAX Rabies Vaccine Vials to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $4,128.11, was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the federal government. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is May 31, 2024. The contract...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of IMOVAX Rabies Vaccine vials to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The $2,281.90 firm fixed-price delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a wide range of...
This federal contract award is for the delivery of IMOVAX RABIES VACCINE VIALS to the Defense Logistics Agency (DLA). The $1,295.22 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that supplies medical products to federal government agencies. The contract has an ultimate completion date of October 25, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award is for the supply of IMOVAX rabies vaccine vials to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $2,158.70, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on June 28, 2024. The contract is a delivery order with a firm fixed price and a completion date of July 1, 2024. Amerisourcebergen, through its Corporate Office Division, is the prime contractor and there is no...
This federal contract award is for the delivery of IMOVAX RABIES VACCINE VIALS to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order with a ceiling value of $4,533.27 and a performance period through April 11, 2024. No set-aside designation was used for this...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide IMOVAX Rabies Vaccine vials. The contract has a potential value of $5,267.14 and a completion date of February 21, 2024. This award is part of Amerisourcebergen's larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, to deliver pharmaceutical products and medical supplies to DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,004.75 firm fixed-price delivery order is for the supply of IMOVAX Rabies Vaccine Vials. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,238.05 firm fixed price Delivery Order is for the supply of IMOVAX Rabies Vaccine Vials. The contract has an ultimate completion date of July 15, 2024. Amerisourcebergen, a large pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle to provide a...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB24FPDN1
    Delivery Order

The federal contract award is to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of IMOVAX RABIES VACCINE VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract has an award value of $1,295.22 and a performance period through August 16, 2024. It is a firm-fixed-price delivery order contract. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with the DLA for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This particular award does not have a set-aside designation.

Generated 11/14/24, 9:17 AM